Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene
Michele M P Lufino1, Pauline A H Edser, Richard Wade-Martins
1Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
Summary
Extrachromosomal vectors offer a safer gene therapy alternative by persisting without integrating into the host genome. These episomal vectors enable precise transgene expression, particularly in stem cells for therapeutic applications.
Area of Science:
- Gene Therapy
- Molecular Biology
- Biotechnology
Background:
- Integrating gene therapy vectors raise safety concerns due to potential genome disruption.
- Extrachromosomal (episomal) vectors offer a non-integrating alternative for gene delivery.
- Recent advancements enhance the safety and regulation of gene therapy vectors.
Purpose of the Study:
- To review advances in extrachromosomal vector technology for gene therapy.
- To discuss mechanisms, delivery methods, and applications of episomal vectors.
- To explore the potential of extrachromosomal vectors in stem cell therapy.
Main Methods:
- Review of current literature on extrachromosomal vector systems.
- Analysis of vector retention mechanisms and insert capacity.
- Evaluation of viral and nonviral delivery systems for episomal vectors.
Main Results:
- Extrachromosomal vectors provide safer, physiologically regulated gene expression.
- They avoid genomic disruption, making them suitable for stem cell applications.
- High insert capacity allows for genomic context expression and normal splice variants.
Conclusions:
- Extrachromosomal vectors represent a promising advancement in gene therapy safety.
- Their non-integrating nature and ability to express genomic DNA loci are key advantages.
- Potential applications in stem cell therapy offer exciting therapeutic prospects.
